Production and Revenue - Q4 2025 run-rate daily production reached 25,627 Boe/d, exceeding the mid-point of guidance[1] - Q4 2025 total revenues amounted to $82.5 million, with net income of $24.8 million and net income attributable to common units of $19.2 million[11] - For Q4 2025, total revenues increased to $82.453 million, up from $66.715 million in Q4 2024, marking a year-over-year growth of approximately 23%[33] - For the full year 2025, total revenues reached $333.830 million, an increase from $309.307 million in 2024, representing a growth of about 8%[35] - The average realized price per barrel of oil in Q4 2025 was $58.24, with total revenues from oil, natural gas, and NGLs at $76.0 million[11] Financial Performance - The company reported a net income of $24,804 million for Q4 2025, compared to a net loss of $39,259 million in Q4 2024[33] - Kimbell's net income for the year ended December 31, 2025, was $99.651 million, significantly higher than the $11.070 million reported in 2024[35] - The company’s basic earnings per common unit for 2025 was $0.62, compared to a loss of $0.12 per unit in 2024[35] - Consolidated Adjusted EBITDA for Q4 2025 was $64,825,000, compared to $59,776,000 in Q4 2024, reflecting an increase of 8.5%[42] - Adjusted EBITDA attributable to Kimbell Royalty Partners, LP for Q4 2025 was $56,117,000, up from $50,684,000 in Q4 2024, marking an increase of 10.0%[42] Cash Distribution and Debt Management - Q4 2025 cash distribution was announced at $0.37 per common unit, up 6% from Q3 2025, reflecting a payout ratio of 75% of cash available for distribution[9] - Kimbell plans to maintain a payout ratio of 75% of projected cash available for distribution, using the remaining 25% to reduce outstanding borrowings[24] - Kimbell paid down approximately $57.4 million on its credit facility during 2025, allocating 25% of cash available for distribution for debt repayment[5] - As of December 31, 2025, Kimbell had approximately $441.5 million in debt outstanding, with a net debt to trailing twelve-month consolidated Adjusted EBITDA ratio of approximately 1.5x[15] - Long-term debt as of December 31, 2025, was $441,500,000, with net debt at $397,523,000, resulting in a net debt to trailing twelve-month consolidated adjusted EBITDA ratio of 1.5x[46] Operational Insights - Proved developed reserves increased by approximately 8% year-over-year to nearly 73 million Boe, reflecting ongoing development and acquisitions[21] - Kimbell's major properties had 85 active rigs drilling, representing a 16.1% market share of U.S. land rigs as of December 31, 2025[18] - The company initiated 2026 operational guidance with estimated daily production projected at a mid-point of 25,500 Boe/d, unchanged from 2025[8] - Kimbell Royalty Partners projects net production for 2026 to be between 24.0 Mboe/d and 27.0 Mboe/d, with oil production expected to account for 30% to 34% of net production[24] - The company anticipates natural gas production to represent 46% to 50% of net production, while natural gas liquids production is expected to be 18% to 22%[24] Cost Management - Unit costs for marketing and other deductions are projected to range from $1.40 to $2.20 per boe, with depreciation and depletion expenses expected between $13.00 and $20.00 per boe[24] - Net cash provided by operating activities for Q4 2025 was $57,226,000, an increase from $56,571,000 in Q4 2024, representing a growth of 1.2%[40] - Cash available for distribution on common units in Q4 2025 was $46,836,000, compared to $41,502,000 in Q4 2024, indicating a rise of 12.0%[42] - The cash available for distribution per common unit outstanding in Q4 2025 was $0.50, an increase from $0.44 in Q4 2024[42] - The fourth quarter 2025 distribution declared was $0.37 per common unit, compared to $0.40 in Q4 2024[42] Asset Performance - The impairment of oil and natural gas properties was zero in Q4 2025, compared to $56,155,000 in Q4 2024, indicating improved asset performance[40] - Kimbell Royalty Partners owns mineral and royalty interests in over 17 million gross acres across 28 states, including more than 133,000 gross wells[27] - The total common units outstanding increased from 80,969,651 on December 31, 2024, to 93,396,488 on December 31, 2025[42]

Warner Bros. Discovery Reports Fourth-Quarter and Full-Year 2025 Results | | | | Three Months Ended December 31, | | | | Twelve Months Ended December 31, | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 2025 | 2024 | % Change | | 2025 | 2024 | % Change | | | $ in millions | | | | Reported | Ex-FX(') | | | Reported | Ex-FX(') | | Distribution | କି | 4,789 | 49 4,917 | (3)% | $ (3)% | 19,262 | $ 19,701 | (2)% | (2)% | | Advertising | | 1,703 | 1.830 | (7)% | (9)% | 7,306 | 8,090 | (10 ...

Exhibit 99.1 Investor Contact: Mark Melnyk 407-613-3327 mark.melnyk@hgv.com Media Contact: Lauren George 407-613-8431 lauren.george@hgv.com FOR IMMEDIATE RELEASE Hilton Grand Vacations Reports Fourth Quarter and Full Year 2025 Results ORLANDO, Fla. (Feb. 26, 2026) – Hilton Grand Vacations Inc. (NYSE: HGV) ("HGV" or "the Company") today reports its fourth quarter and full year 2025 results. Fourth quarter of 2025 highlights 1 Full Year 2026 Outlook • The Company expects full-year 2026 Adjusted EBITDA attribu ...

Financial Performance - Total revenue for 2025 increased 14% to $2.09 billion, with organic revenue growth of 3.7%[1][12] - Net income rose 9% to $255 million, with diluted earnings per share increasing 14% to $3.42[1][4] - Adjusted EBITDA increased 25% to $553 million for the year[1][4] - Revenue for the year ended December 31, 2025, was $2,093 million, an increase of 13.6% from $1,843 million in 2024[40] - Net income for 2025 was $255 million, compared to $235 million in 2024, representing an increase of 8.5%[40] - Adjusted EBITDA for the year ended December 31, 2025, reached $553 million, a rise of 25% from $443 million in 2024[49] Profitability Metrics - Gross profit margin expanded by 150 basis points to 55%[1][4] - Gross profit for 2025 was $1,157 million, up from $991 million in 2024, reflecting a gross margin improvement[40] - Free cash flow for the year ended December 31, 2025, was $390 million, compared to $231 million in 2024, indicating a significant increase of 69%[48] Cash Flow and Liquidity - Net cash provided from operating activities increased 54% to $416 million for the year[1][17] - Cash provided from operating activities increased to $416 million in 2025, up from $270 million in 2024, representing a growth of 54%[44] - Cash and cash equivalents increased to $566 million in 2025 from $421 million in 2024, enhancing liquidity position[41] - Cash and cash equivalents at the end of the period increased to $566 million in 2025, up from $421 million in 2024[44] Shareholder Actions - The company repurchased $280 million of shares in 2025, representing 7% of total shares[1][3] - The company repurchased $283 million worth of common stock in 2025, compared to $161 million in 2024, marking a 76% increase[44] Future Projections - For 2026, revenue is projected to be between $2.155 billion and $2.195 billion, reflecting a 3% to 5% increase over 2025[1][22] - The company aims for a long-term adjusted EBITDA margin outlook in the mid-20% range[1][3] - Home warranty member count is expected to turn positive in 2026, driven by a projected 5% increase in first-year home warranty members[1][22] - Non-warranty and other revenue is anticipated to be between $220 million and $240 million in 2026[1][22] Debt Management - Long-term debt decreased to $1,144 million in 2025 from $1,170 million in 2024, indicating improved debt management[41] Customer Metrics - The number of home warranties as of December 31, 2025, was 2.11 million, slightly down from 2.12 million in 2024, reflecting a 0% change[51] - Customer retention rate decreased to 79.2% in 2025 from 79.9% in 2024[51] Acquisition Impact - The acquisition of 2-10 Home Buyers Warranty is expected to enhance market position, though risks remain regarding its integration[29] Depreciation and Amortization - The company reported a depreciation and amortization expense of $89 million for the year ended December 31, 2025, compared to $39 million in 2024[44] Loss on Debt Extinguishment - The company experienced a loss on extinguishment of debt of $3 million in 2024, with no such loss reported in 2025[44]

BLACKSKY REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS "Growing demand and new Gen-3 contract awards drove a strong Q4 and delivered a second consecutive year of positive adjusted EBITDA," said Brian E. O'Toole, BlackSky CEO. "With the exceptional performance of Gen-3, we're converting early customer pilots into long-term subscription contracts worldwide. Significant international demand drove the majority of our backlog growth and is further diversifying our customer base. We enter 2026 with strong mom ...

Exhibit 99.1 Tecnoglass Reports Fourth Quarter and Full Year 2025 Results - Full Year Revenues Increased 10.5% to a Record $983.6 Million Through Market Share Gains, Geographical Expansion and Increased Demand for Vinyl Products - - Full Year Single-Family Residential Revenue Grew to a Record $403.4 Million - - Record Full Year Gross Profit of $421.4 Million, Representing 42.8% of Revenues - - Full Year Net Income of $159.6 Million, or $3.42 Per Diluted Share; Full Year Adjusted Net Income of $167.0 Million ...

Vital Farms Reports Fourth Quarter and Fiscal Year 2025 Financial Results Fiscal Year 2025 Net Revenue of $759.4 million, up 25.3% versus Fiscal Year 2024 Fiscal Year 2026 Guidance of $900 to $920 million for Net Revenue, representing up to 21% Growth from 2025; Guidance of $105 to $115 million for Adjusted EBITDA and $140 to $150 million for Capital Expenditures; Remains on Track to Reach $2 Billion Net Revenue Target by 2030 $100 Million 2-year Stock Repurchase Program Authorization Successful Remediation ...

Financial Performance - Ligand reported total revenues of $59.7 million for Q4 2025, a 39% increase from $42.8 million in Q4 2024, primarily driven by a 45% increase in royalty revenue to $50.5 million[3]. - For the full year 2025, total revenues were $268.1 million, up from $167.1 million in 2024, with royalties increasing to $161.0 million from $108.8 million[7]. - GAAP net income for Q4 2025 was $44.8 million, or $2.12 per diluted share, compared to a net loss of $31.1 million, or $1.64 per share, in Q4 2024[5]. - Adjusted net income for Q4 2025 was $42.7 million, or $2.02 per diluted share, up from $25.2 million, or $1.27 per diluted share, in Q4 2024[6]. - Ligand's full year 2025 GAAP net income was $124.5 million, or $6.13 per diluted share, compared to a net loss of $4.0 million, or $0.22 per share, in 2024[9]. - Total revenues and income for Q4 2025 reached $59.666 million, a 39.4% increase from $42.812 million in Q4 2024[31]. - Net income for the year ended December 31, 2025, was $124.453 million, compared to a net loss of $4.032 million in 2024[31]. - Adjusted net income for the year was $165.058 million, compared to $156.041 million in 2024, showing consistent profitability[35]. Guidance and Future Outlook - The company is reaffirming its 2026 financial guidance, expecting total revenues between $245 million and $285 million, with adjusted earnings per diluted share of approximately $8.00 to $9.00[10]. - Ligand's forward-looking statements include guidance regarding projected 2026 financial results, with actual results subject to various risks and uncertainties[24]. Research and Development - Research and development expenses for the full year 2025 were $81.2 million, significantly up from $21.4 million in 2024, primarily due to one-time charges related to royalty financing agreements[8]. - Research and development expenses for the year increased to $81.182 million, up from $21.425 million in 2024, reflecting a focus on innovation[31]. - R&D funding expenses increased to $3.25 million, indicating a focus on innovation and development[36]. Cash and Assets - As of December 31, 2025, Ligand had cash, cash equivalents, and short-term investments totaling $733.5 million[6]. - Cash, cash equivalents, and short-term investments rose to $733.521 million as of December 31, 2025, compared to $256.165 million in 2024[33]. - Total assets increased to $1.561 billion in 2025, up from $941.774 million in 2024, indicating strong growth[33]. - Total liabilities were $543.425 million in 2025, compared to $111.335 million in 2024, reflecting increased financial commitments[33]. Business Model and Strategy - Ligand's business model focuses on generating value through a diversified portfolio of biotech and pharmaceutical product revenue streams supported by a low corporate cost structure[22]. - Ligand operates two royalty-generating technology platforms: Captisol and NITRICIL, aimed at optimizing drug solubility and stability[22]. Transactions and Partnerships - Captisol sales for Q4 2025 were $7.8 million, slightly down from $7.9 million in Q4 2024, while full year Captisol sales increased to $40.2 million from $30.9 million in 2024[3][7]. - The company recognized a total income of $53.1 million from the divestiture of its Pelthos subsidiary, which included $24.5 million from the out-license of Zelsuvmi and a $28.6 million gain on the sale of the business[39]. - On November 7, 2025, Pelthos Therapeutics acquired U.S. commercialization rights to Xepi, with Ligand entitled to a low single-digit royalty on net sales[19]. - On December 18, 2025, Athira, now Leona Bio, acquired rights to lasofoxifene, with Ligand entitled to a tiered 6-10% royalty on future net sales[19]. Impairments and Losses - Financial royalty asset impairment for the full year 2025 was $6.2 million, down from $30.6 million in 2024, reflecting changes in partnered programs[8]. - Impairment of financial royalty assets amounted to $1.62 million, primarily related to Agenus returned partner programs and the discontinuation of Takeda's soticlestat program[36][37]. - The company reported a loss from equity method investment in Primrose Bio of $0.37 million, reflecting challenges in that investment[36]. - The company experienced a downward adjustment of $25.8 million in the price of the Primrose Bio Series A Preferred Shares, highlighting volatility in equity investments[38]. Tax and Adjustments - The income tax effect of adjusted reconciling items was $0.11 million, showing the impact of tax adjustments on net income[36]. - The company excluded $28.6 million related to the gain on the sale of the Pelthos business from adjusted net income to enhance transparency[39].

Exhibit 99.1 Bentley Systems Announces Fourth Quarter and Full Year 2025 Results and 2026 Financial Outlook Declares Quarterly Dividend EXTON, PA – February 26, 2026 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced results for the quarter ended December 31, 2025 and its financial outlook for 2026. Fourth Quarter 2025 Results • Total revenues were $391.6 million, up 11.9% or 9.7% on a constant currency basis, year-over-year; • Subscriptions reven ...

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results -- Company on track to report ELEVATE-44-201 data from Cohort 1 in Q2 2026 and Cohort 2 by year-end 2026 -- Expanding Preclinical Pipeline: The Company has generated compelling preclinical data from programs focused on ocular and metabolic diseases. The pipeline includes the advancement of two novel oligonucleotide-based programs for the potential treatment of inherited retinal diseases, where there exists high unmet need. The ...